3D Systems Corporation Q1 2026 Earnings Recap

Shares surged 23.9% post-earnings, reflecting strong growth in printer, parts, and healthcare materials sales, with industry-leading product innovation and expanding addressable markets driving investor enthusiasm.

Key Takeaways

• Double-digit year-over-year growth in printer sales and materials across healthcare and industrial segments.
• Momentum in medical parts manufacturing, particularly titanium spinal and cobalt chrome joint implants, fueled growth despite a temporary disruption at a key customer.
• Dental material sales advanced strongly, supported by increased demand for aligners and prosthetic materials under the Vertex brand, now expanded in the U.S. market after regulatory approval.
• Successful launch of NextDent 300 denture printing system with early commercial traction, including major deployment by ROE Dental Labs tripling their manufacturing capacity.
• Regulatory milestones achieved ahead of schedule, expanding total addressable market to over 60 million edentulous patients globally with multibillion-dollar digital dentistry opportunity.